The use of 96-well plate assays to examine the effects of heat shock protein 47 (HSP47) inhibition on platelet aggregation provides valuable insights into therapeutic strategies aimed at modulating thrombotic diseases. The gene discussed is SERPINH1; the disease is thrombotic disease.